Search results
Filter
Filetype
Your search for "2024" yielded 24261 hits
Grants for seminars, symposia, and lectures on European themes
HIV-2 mediated effects on target and bystander cells induce plasma proteome remodeling
HIV-2 mediated effects on target and bystander cells induce plasma proteome remodeling Emil Johansson 1 2, Jamirah Nazziwa 1 2, Eva Freyhult 3, Mun-Gwan Hong 4, Jacob Lindman 5, Malin Neptin 1 2, Sara Karlson 2 6, Melinda Rezeli 7, Antonio J Biague 8, Patrik Medstrand 1 2, Fredrik Månsson 1, Hans Norrgren 5, Joakim Esbjörnsson 1 2 9, Marianne Jansson 2 6; SWEGUB CORE groupAffiliations1Department o
This year's medical award from the LMK Foundation to Elin Trägårdh!
Elin Trägårdh is a professor of clinical physiology and nuclear medicine at Lund University affiliated to the Wallenberg centre of Molecular Medicine and a chief physician at Skåne University Hospital. She is recognized for her interdisciplinary research that combines high-tech imaging research at the cellular level with clinical care for patients with prostate cancer. The field of medical imaging
https://www.wcmm.lu.se/article/years-medical-award-lmk-foundation-elin-tragardh - 2026-05-03
The premises programme and next steps for the Science Village establishment (Stage 2)
In December last year (2023), the project group for Lund University's Science Village establishment (Stage 2) presented a comprehensive premises programme for Scenario 5, developed in collaboration with White arkitekter. This programme is a detailed description of the premises and functions needed to ensure efficient operations in the future. It marks the first, but very important, step towards th
https://www.science.lu.se/internal/article/premises-programme-and-next-steps-science-village-establishment-stage-2 - 2026-05-03
Blocks aquaporins, thereby inhibiting cancer growth
Aquaporins are proteins that regulate the flow of water in and out of cells. These proteins have been found to play a role in both cancer and type 2 diabetes. Now, a research group at Lund University has succeeded in finding a drug candidate that binds to the protein, something that has been shown to affect the growth capability of leukemia cells. The study is published in PNAS. Aquaporins are wat
https://www.medicine.lu.se/article/blocks-aquaporins-thereby-inhibiting-cancer-growth - 2026-05-03
New faculty course: Better leaders imply stronger research environments
To further professionalise the leadership role, the faculty management, in collaboration with the University's central HR section, has developed a year-long leadership programme to be offered to senior lecturers or newly appointed professors. Lena Eliasson, Vice Dean with special responsibility for employeeship, work environment and infrastructure, explains. Why have you developed a new leadership
https://www.intramed.lu.se/en/article/new-faculty-course-better-leaders-imply-stronger-research-environments - 2026-05-03
International Development Research PhD Workshop Held in Lund
13 doctoral researchers from universities across Europe and Africa gathered in Lund to present their ongoing work and discuss development research topics. On 23 - 24 October, the Development Research School hosted an international PhD workshop in Lund (Sweden) with the purpose of bringing development research doctoral students from a broad range of backgrounds together. The event was an opportunit
https://www.developmentresearchschool.lu.se/article/international-development-research-phd-workshop-held-lund - 2026-05-03
Researcher draws attention to dark report on greenhouse gases
Physical geographer Alex Vermeulen, who leads the work on the ICOS Carbon Portal, was the editor of a new publication on greenhouse gas flows that has received significant international recognition. It was recently presented at the UN Climate Summit in Baku. Alex, you've been working with the Greenhouse Gas Bulletin again this year. What do the results look like?– Concentrations of all major green
https://www.science.lu.se/article/researcher-draws-attention-dark-report-greenhouse-gases - 2026-05-03
The medication Wegovy for obesity will not receive reimbursement
On Monday, 23 February, the Swedish Dental and Pharmaceutical Benefits Agency (TLV) announced its decision. They have declined to subsidize Wegovy, which has quickly become one of the most discussed medications for obesity. Wegovy, which contains the now well‑known substance semaglutide, is used to help people with obesity lose weight. Novo Nordisk, the company behind the drug, had applied for it
https://www.arthritisportal.lu.se/article/medication-wegovy-obesity-will-not-receive-reimbursement - 2026-05-03
They are going on research adventures abroad
Three travel grant applications from SWEAH PhD-students have been approved this spring. Sharon Kagwa, Karolinska Institutet, will visit to the non-governmental organisation SAJIDA foundation in Bangladesh, in June- August this summer.– I am mostly looking forward to being exposed to new research methodologies and perspectives within a new research setting in a middle-income country. This internshi
https://sweah.lu.se/en/article/they-are-going-research-adventures-abroad - 2026-05-03
WISE grants to four projects at the Department of Physics
Four PhD and postdoctoral projects at the Department of Physics are awarded funding in the second academic call from WISE. In total, 54 projects across the country will share SEK 166 million. WISE, Wallenberg Initiative Materials Science for Sustainability, is Sweden´s largest-ever investment in materials science. The aim is to enable sustainable development through basic and needs-driven material
https://www.fysik.lu.se/en/article/wise-grants-four-projects-department-physics - 2026-05-03
International Day of the Midwife: Sustainability in focus
Workshop on citizen engagement in the climate-transition
Worlds in the Making: Viability, Orientation and Recalibration in Syrian Lives
How do Syrians navigate uncertainty and reshape their futures after years of conflict and upheaval? This question was at the heart of the CMES seminar “Worlds in the Making: Viability, Orientation and Recalibration in Syrian Lives,” with Andreas Bandak, University of Copenhagen. The event brought together students, researchers and practitioners to reflect on the shifting realities, challenges, and
https://www.cmes.lu.se/article/worlds-making-viability-orientation-and-recalibration-syrian-lives - 2026-05-03
Omega-3 can alleviate symptoms in depressed patients with inflammation
How might low-grade inflammation be linked to depression? New research findings show that depression can be alleviated when patients with mild elevations of inflammatory markers in blood samples take omega-3 supplements. The antidepresssant effect was greater in those with low-grade inflammation than in those with no inflammation. “We saw a significant improvement in symptom severity,” says resear
https://www.medicine.lu.se/article/omega-3-can-alleviate-symptoms-depressed-patients-inflammation - 2026-05-03
The recipe for a great antibody
Antibodies are the body's superheroes, recognizing and eliminating disease-causing substances. By combining parts from antibodies, researchers at Lund University have designed a hybrid antibody that better stimulates the immune system against both the SARS-CoV-2 virus and streptococcal bacteria. Antibodies can be likened to keys, with antigens as the corresponding locks. Each antibody is uniquely
https://www.medicine.lu.se/article/recipe-great-antibody - 2026-05-03
Protein that affects the ability to secrete insulin in type 2 diabetes
In type 2 diabetes, the body's ability to release insulin is impaired, which leads to high blood glucose levels. Research led from Lund University shows how the levels of a particular protein are elevated in the pancreas of people with type 2 diabetes. By knocking out the gene for the protein IGFBP7, the researchers discovered that insulin secretion was improved. Reduced insulin secretion leads to
https://www.medicine.lu.se/article/protein-affects-ability-secrete-insulin-type-2-diabetes - 2026-05-03
Groundbreaking Alzheimer’s blood test proves highly effective in primary healthcare
A commercially available blood test has now been trialled in routine healthcare. “The blood test showed about 90% reliability even in primary care. This may have major implications for all those individuals who seek help for memory loss and suspected Alzheimer’s,” say the researchers at Lund University in Sweden behind the study. Alzheimer’s disease affects one in five women and one in ten men ove
https://www.multipark.lu.se/article/groundbreaking-alzheimers-blood-test-proves-highly-effective-primary-healthcare - 2026-05-03
